Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#PTCLTreatment

Home » #PTCLTreatment
Efficacy & safety of Mitoxantrone Liposome in treating peripheral T-cell lymphomas: A real-world study (MOMENT)

Efficacy & safety of Mitoxantrone Liposome in treating peripheral T-cell lymphomas: A real-world study (MOMENT)

Posted by By Lisa Cui 2024.01.18
Efficacy and safety of mitoxantrone hydrochloride liposome injection in treatment of peripheral T-cell lymphomas: a multicenter, non-interventional, ambispective cohort, real-world study (MOMENT) In August 2023, Professor Jun Ma and his…
Read More
Dr. Xu Pengpeng: Preliminary Results of Targeted Drug Combination with CHOP as First-Line Treatment for PTCL

Dr. Xu Pengpeng: Preliminary Results of Targeted Drug Combination with CHOP as First-Line Treatment for PTCL

Posted by By Lisa Cui 2024.01.08
Peripheral T-cell lymphoma (PTCL) is a heterogeneous disease with poor prognosis. Standard CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) chemotherapy is the most widely used regimen for first-line treatment of PTCL.…
Read More
Recent Posts
  • 2025 Yat-sen Breast Cancer Conference丨Professor Jing Yao: Addressing the Multiple Unique Needs of Young Breast Cancer Patients and Optimizing Treatment Choices Through Patient-Centered Care
  • SABCS 2025 Insight Broadcast丨Professor Junjie Li: Exploring Precision Biomarkers for Neoadjuvant Therapy in HER2-Positive Breast Cancer
  • SABCS 2025 Insight Broadcast: Professor Jin Yang: Interpreting the New Landscape of First-Line Advanced and Early Adjuvant Therapy for HR+/HER2− Breast Cancer
  • SABCS Hot Commentary:Professor Xiaoyun Mao: A Breakthrough in “Intensified” First-Line Maintenance Therapy for HER2-Positive Metastatic Breast Cancer
  • The 17th Shanghai Breast Cancer Professional Symposium 丨Professor Benlong Yang: Exercising Caution in Surgical Indications for Advanced Breast Cancer and Strictly Upholding the Threshold for Prophylactic Mastectomy
Recent Comments
    Archives
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top